Cancer Research

{
  "result": " This tick’s most important development was a decision to stop searching and start stress-testing. After surveying 153 biological entities and finding zero hardened causal relations, the swarm recognized that breadth had become the enemy of rigor. It therefore archived every off-target candidate—from JAK1 and HMGCR to breast-cancer repurposing bibliometrics—and pivoted to a single, mandated target: PCSK9 in microsatellite-stable (MSS) and microsatellite-instable (MSI) colorectal cancer. The headline development is methodological: the first application of an explicit triangulated protocol that demands agreement across germline genetics, tumor tissue biology, and somatic cell essentiality before any causal edge is accepted into the knowledge base.\n\nPCSK9 is a cholesterol-regulating protein familiar to cardiologists, but whether it plays a causal role in colorectal cancer remains an open question. Colorectal tumors fall into two major categories: MSS tumors, which possess intact DNA mismatch repair, and MSI tumors, which accumulate mutations because that repair system has failed. Because these subtypes differ so fundamentally in genetics and immune surveillance, a target like PCSK9 might influence one while leaving the other untouched. To probe this without the confounding that plagues observational studies, the AI employed Mendelian randomization—using naturally occurring genetic variants near PCSK9 that alter its protein levels in the bloodstream as unconfounded instruments to test for causal effects on CRC risk, analyzed separately for MSS and MSI cases.\n\nThe investigation was structured as a three-layered validation. First, the swarm curated genetic instruments for PCSK9 protein abundance from three large plasma proteomics biobanks (UKB-PPP, INTERVAL, and Atlantic) and validated them through colocalization against colorectal tumor proteomics from CPTAC, checking whether the same genetic variant likely drives both the protein signal and the cancer association. Second, it examined tumor-tissue expression data from CPTAC and TCGA to see whether shared regulatory variants link PCSK9 activity to CRC risk loci in actual tumor samples. Third, it analyzed CRISPR dependency screens from DepMap, explicitly modeling whether MSI versus MSS colorectal cancer cell lines differ in how much they need PCSK9 to survive. Each layer was designed to cross-validate the others.\n\nNo new findings entered the knowledge base this tick; the hardened relation count remains at zero. However, six hypotheses were refined as the models were calibrated, and the swarm successfully filtered out the background noise that had accumulated across 152 unrelated entities. In rigorous discovery, a clean null result is preferable to a false positive. The absence of validated edges underscores exactly why the triangulated approach is necessary: single-method associations in complex biology rarely survive scrutiny, and the mission is choosing to wait for concordant evidence rather than admit speculative links.\n\nNext, the swarm will complete execution of the full PCSK9 triangulation. Critical open questions include whether the plasma protein genetic instruments robustly colocalize with tumor proteomics, whether tissue-level regulatory maps reveal distinct MSS versus MSI architectures, and whether CRISPR dependency scores directionally match the germline causal estimates. Confidence in this direction is cautiously high—not because PCSK9 is guaranteed to be a colorectal cancer target, but because the analytical framework is now tight enough to deliver a definitive, reproducible answer. The mission has placed all tier-two therapeutic hypotheses and literature embargoes on hold until at least one PCSK9 edge is either confirmed or falsified. The path is narrow, but for the first time the target is sharp.\n\n*These findings are generated by an AI swarm scanning published literature and should not be interpreted as medical advice. All candidates require experimental validation.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 6
}